Respiratory Drug Delivery Conference

May 5-9 | Tucson, Arizona , USA

Proveris Scientific and contract test services division Proveris Laboratories will host an exhibition table and present two posters at the Respiratory Drug Delivery (RDD 2024). The poster presentations will cover topics: ‘Inhalation and Exhalation Airflow Resistance of Valved Holding Chambers,’ and ‘Methodology for Measurement of Evaporation Fraction and Evaporation Rate, A Comparison Of HFA-134a And HFA-152a pMDI Formulations.’

Representatives from Proveris will also be available throughout the conference. To find out more, or to arrange a meeting, please email contactus@proveris.com. 

 Respiratory Drug Delivery, RDD®, is an international conference for researchers, regulators, business professionals and suppliers active in pulmonary and nasal drug delivery. It provides a venue for expert speakers to cover topics including new therapeutic opportunities, drug delivery technologies, regulatory science, and novel in vitroin vivo and clinical testing methods.

Learn more and register HERE.

11th DPI China Technology Conference

March 21-22 | Hangzhou, China

Proveris Scientific experts and partner Ruty Li of Quantflux will share latest solutions at their exhibition table during the 11th DPI China Technology Conference. Ben Okorodudu, Vice President of Sales for Proveris Scientific will give a presentation on ‘Quantification of Pulmonary Drug Deposition: A Novel In Vitro Tool’ and discuss:

  • A complimentary deposition tool to APSD for early product deposition assessment
  • Characterization of particle/droplet size deposition properties 
  • Drug deposition using human-realistic breathing

Representatives from Proveris will also be available throughout the conference. To find out more, or to arrange a meeting, please email contactus@proveris.com. 

DPI China Technology Conference focus is on the new technology, market trends, regulatory guidance for dry powder inhaler (DPI) development. It provides the platform to network with local and global industry. Presentations will be held by renowned experts in the field of development of DPI products.

Learn more and register HERE. 

2nd Novel Nasal Formulation & Delivery Summit

March 12-14 | San Diego, California, USA

Experts from Proveris Laboratories, the contract test services division of Proveris Scientific Corporation will host an exhibition table and give a scientific presentation at the 2nd Novel Nasal Formulation & Delivery Summit.  The presentation on ‘Guide to the Effects of Product Development on Nasal Spray Performance’ will provide attendees with an understanding of the importance of human-realistic testing, the impact of viscosity and other factors on nasal deposition, and the effect of product changes on performance.

Representatives from Proveris will also be available throughout the conference. To find out more, or to arrange a meeting, please email contactus@proveris.com. 

The Novel Nasal Formulation & Delivery Summit serves as a platform for experts, researchers, and industry professionals to come together and exchange knowledge, experiences, and innovative solutions. Attendees will learn how to propel non-invasive therapeutics through nasal drug delivery route and increase patient adherence across the next generations of vaccines, CNS, and respiratory indications.

Learn more and register HERE.

DDL 2023

December 7-9 | Edinburgh, Scotland

Proveris is a sponsor, exhibitor, and poster presenter at the Drug Delivery to The Lungs (DDL) conference which will be held December 7-9. 

If you would like to learn more and schedule a meeting with us, email us at contactus@proveris.com.

Drug Delivery to the Lungs (DDL) is an annual conference covering all aspects of respiratory drug delivery. It attracts a wide variety of attendees, including scientists, academics, clinicians, regulators, and industry experts. It offers a venue for lectures, posters, and exhibitions.

Learn more and register HERE.

IDDA 2023

November | Beijing, China

Proveris Scientific’s partner in China, Ruty Li of Quantflux, will attend the Inhalation Drug Delivery Association Conference. He will be at the Proveris table in the exhibit area and will give a scientific presentation on behalf of Proveris.

If you would like to learn more and schedule a meeting with him, email us at contactus@proveris.com.

The Inhalation Drug Delivery Association Conference brings together well-known academics, experts, and scholars from China and around the world.  The conference provides a venue for the industry to exchange information, academic views, technologies and interactive communication on applications, laws and regulations, clinical research, market conditions.

IRDD US Congress 2023

October 2-3 | San Diego, USA

Proveris experts will give a presentation and meet with attendees as an exhibitor at the 5th Annual Inhalation & Respiratory Drug Delivery US (IRDD US) Congress.

If you would like to learn more and schedule a meeting with us, email us at contactus@proveris.com.

The IRDD US Congress delivers breakthrough research, technologies & connects global pharma, biotech and academia for high-level discussions on the latest innovations in formulation, drug delivery & inhaled science.

Exceptional speakers discuss the latest challenges and innovations in inhaled therapies formulation, delivery and moving towards sustainable device development

Learn more and register HERE.

6th Inhalation China Symposium

October 2023 | China

Proveris Scientific’s partner in China, Ruty Li of Quantaflux, will attend the 6th Inhalation China Symposium. He will be at the Proveris table in the exhibit area and will give a scientific presentation on behalf of Proveris.

If you would like to learn more and schedule a meeting with him, email us at contactus@proveris.com.

Inhalation China Symposium is organized by Fudan University School of Pharmacy, Pharmaceutical Preparation Committee of Shanghai Pharmaceutical Association, and co-organized by Reed Sino Pharma and Shanghai Pharma. Experts from Central CFDA, Local CFDA, technology companies, R&D organizations, universities, and hospitals speak about current topics related to inhalation drug delivery science, applications, and technology.

8th Pulmonary Drug Delivery

May 31-June 2 | Istanbul, Turkey

Proveris is a presenter at the 8th Drug Delivery Workshop which will be held from May 31-June 2.

Our presentation entitled ‘Spray Characterization for In Vitro Bioequivalence’ will be given by Dr. Deborah Jones, EMEA Director of Sales. The presentation focus is on in vitro nasal drug development solutions for the Turkish pharma market and will include new measurements of interest for pMDI and Soft Mist drug development.

If you would like to learn more and schedule a private meeting with us, email us at contactus@proveris.com.

The Pulmonary Drug Delivery Workshop (PDD) series aim is to provide a space for discussions on research and engagement in new collaborations. It’s a forum for learning about inhalation drug delivery from leaders in the field and discuss aerosol-related topics in a relaxed atmosphere. 

Learn more and register HERE.

Novel Formulation & Delivery Summit

May 17-18 | San Diego, USA

Proveris is an expertise sponsor of The Novel Formulation & Delivery Summit which will be held from May 17-18.

Our presentation entitled ‘Using Quality by Design (QbD) to Accelerate Nasal Drug Product Development’ discusses in vitro testing approaches that accommodate the complexity of combination products. The approach incorporates QbD into the very early development phase and facilitates a streamlined scale-up during commercialization.

If you would like to learn more and schedule a private meeting with us, email us at contactus@proveris.com.

The Novel Nasal Formulation & Delivery Summit is a unique forum set to unite 60 plus pioneers in nasal drug development. Speakers will reveal enlightening content focusing on novel formulation and delivery techniques for both acute and chronic disease indications. Attendees will learn how to propel non-invasive therapeutics through nasal drug delivery route and increase patient adherence across the next generations of vaccines, CNS, and respiratory indications.

Learn more and register HERE.

RDD Europe 2023

May 2-5 | Nice, France

Proveris is an exhibitor, workshop presenter, and poster presenter at the Respiratory Drug Delivery (RDD 2023) which will be held in-person and as a virtual event from May 2-5.

Our workshop presentation entitled ‘Synergies of Inhalation Product Development and Spray Characterization’ is in collaboration with Catalent Inhalation. Our poster presentation entitled ‘Comparison of Spray Characteristics of pMDIs with P-134a (current Propellant) and Low-GWP P-152a Propellant with 8% Ethanol and Ethanol-free’ is in collaboration with Koura Global.

If you would like to learn more and schedule a private meeting with us, email us at contactus@proveris.com.

Respiratory Drug Delivery, RDD®, is an international conference for researchers, regulators, business professionals and suppliers active in pulmonary and nasal drug delivery. It provides a venue for expert speakers to cover topics including new therapeutic opportunities, drug delivery technologies, regulatory science, and novel in vitroin vivo and clinical testing methods.

Learn more and register HERE.